Christoph Correll, MD: professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and a medical director of the Recognition and Prevention (RAP) program at Zucker Hillside Hospital. He also currently serves as professor and chair of the Department of Child and Adolescent Psychiatry at Charité University Medicine in Berlin, Germany.
Professor Correll has authored and co-authored more than 900 journal articles that have been cited over 76,000 times, and in April 2024 his Google Scholar h-index was 143. He has been the Principal Investigator or Steering Committee member of several large, federally funded grants and has served on several expert consensus panels on the use of antipsychotics across a range of psychiatric disorders. He has received more than 40 national and international research awards and fellowships for his work. Since 2014, the year of inception of this metric, Professor Correll has been listed each year by Thomson Reuters/Clarivate/Web of Science as one of “The most influential scientific minds” and “Top 1% cited scientists in the area of psychiatry.”
Professor Correll’s research and clinical work focus on the identification, characterization and psychopharmacological management of adults and youth with severe psychiatric disorders. His areas of expertise include schizophrenia, bipolar disorder, major depression and other psychotic, mood and autism/disruptive behavior spectrum disorders, ranging from the prodrome to first episode, multi-episode and refractory illness patients. His work focuses further on psychopharmacology, epidemiology, clinical trials, comparative effectiveness, meta-analyses, the risk–benefit evaluation of psychotropic medications, and the interface between physical health and mental health.